Feed
Deepinder Goyal’s Temple Debates Expose Clinical Validation Gaps in Indian Wearables
Startup

Deepinder Goyal’s Temple Debates Expose Clinical Validation Gaps in Indian Wearables

15 Nov 2026, 11:00 am · 5d ago · 1 min read · Inc42

The ongoing public debate surrounding Zomato founder Deepinder Goyal’s health-tech venture Temple has spotlighted the hurdles facing India’s wearable hardware ecosystem. Temple, which tracks brain blood flow and physiological entropy, sparked controversy regarding marketing claims versus scientific backing. Industry insiders note that India lacks an established playbook, testing infrastructure, and clinical validation pathways for consumer health devices. Wearable makers currently operate in a regulatory grey area where devices track vital physiological metrics without undergoing standard medical device validations, leaving founders struggling with research access, credibility, and red tape.